IDH1 and acute myeloid leukemia: The biological relevance of TET inhibition by 2-HG has strong genetic evidence: gain of function mutations of IDH1/2 and loss of function of TET2 mutations were found to be mutually exclusive in a large AML cohort (Figueroa et al., 2010).